Author

Kathy Hudzina

OpenAlex ID: A5092568899

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial

2023 · Gustavo H Dayan, Nadine Rouphael, et al. · The Lancet Respiratory Medicine · 25

Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study

2023 · Guy de Bruyn, Joyce Wang, et al. · EClinicalMedicine · 22

Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data

2025 · Leah I. B. Andrews, M. Elizabeth Halloran, et al. · JAMA Network Open · 6

Works count: 3

Citation count: 53

H-index: 3

I10-index: 2